COVID-19大流行对接受手术的妇科恶性肿瘤患者的影响:基于荷兰妇科肿瘤审计数据的全国人群研究
该全国人群队列研究纳入2018-2020年荷兰妇科肿瘤审计中所有以治愈为目的的妇科恶性肿瘤手术,共11488例。2020年宫颈癌手术量较2018-2019年下降17.2%,低谷期仅完成预期手术的51%;晚期卵巢癌新辅助化疗比例升高(67.7% vs 61.8%,p=0.011);所有恶性肿瘤首次治疗中位时间显著缩短;并发症和30天死亡率无显著差异。
要点
- 2020年宫颈癌手术量较2018-2019年下降17.2%,低谷期仅完成预期手术的51%。
- 晚期卵巢癌2020年新辅助化疗比例67.7%(n=432),2018-2019年为61.8%(n=783),p=0.011。
- 四种妇科恶性肿瘤2020年首次治疗中位时间均显著缩短,并发症和30天死亡率无显著差异。
核心结论
- COVID-19大流行影响了妇科肿瘤外科医疗:2020年宫颈癌手术量大幅下降,所有恶性肿瘤等待时间显著缩短,晚期卵巢癌新辅助化疗增加。
- 围手术期医疗安全性未受大流行负面影响,并发症和30天死亡率保持稳定。
研究设计与样本
- 基于荷兰妇科肿瘤审计的全国人群队列研究,纳入2018-2020年所有以治愈为目的的妇科恶性肿瘤手术,共11488例手术。
- 根据COVID-19住院率划分四个时期:疫情前、第一波、间歇期和第二波;将2020年数据与2018-2019年比较。
主要发现
- 宫颈癌2020年手术量较2018-2019年下降17.2%(2018-2019年均n=542.5,2020年n=449);低谷期(间歇期)仅完成预期宫颈癌手术的51%。
- 卵巢癌、外阴癌和子宫内膜癌手术量保持稳定。
- 晚期卵巢癌2020年新辅助化疗比例67.7%(n=432),2018-2019年为61.8%(n=783),p=0.011。
- 四种恶性肿瘤2020年首次治疗中位时间均显著缩短;外阴癌和子宫内膜癌2020年住院时间显著缩短。
- 复杂病程和30天死亡率无显著差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The COVID-19-pandemic caused drastic healthcare changes worldwide. To date, the impact of these changes on gynecological cancer healthcare is relatively unknown. This study aimed to assess the impact of the COVID-19-pandemic on surgical gynecological-oncology healthcare. METHODS: This population-based cohort study included all surgical procedures with curative intent for gynecological malignancies, registered in the Dutch Gynecological Oncology Audit, in 2018-2020. Four periods were identified based on COVID-19 hospital admission rates: 'Pre-COVID-19', 'First wave', 'Interim period', and 'Second wave'. Surgical volume, perioperative care processes, and postoperative outcomes from 2020 were compared with 2018-2019. RESULTS: A total of 11,488 surgical procedures were analyzed. For cervical cancer, surgical volume decreased by 17.2% in 2020 compared to 2018-2019 (mean 2018-2019: n = 542.5, 2020: n = 449). At nadir (interim period), only 51% of the expected cervical cancer procedures were performed. For ovarian, vulvar, and endometrial cancer, volumes remained stable. Patients with advanced-stage ovarian cancer more frequently received neoadjuvant chemotherapy in 2020 compared to 2018-2019 (67.7% (n = 432) vs. 61.8% (n = 783), p = 0.011). Median time to first treatment was significantly shorter in all four malignancies in 2020. For vulvar and endometrial cancer, the length of hospital stay was significantly shorter in 2020. No significant differences in complicated course and 30-day-mortality were observed. CONCLUSIONS: The COVID-19-pandemic impacted surgical gynecological-oncology healthcare: in 2020, surgical volume for cervical cancer dropped considerably, waiting time was significantly shorter for all malignancies, while neoadjuvant chemotherapy administration for advanced-stage ovarian cancer increased. The safety of perioperative healthcare was not negatively impacted by the pandemic, as complications and 30-day-mortality remained stable.
引用
- Algera MD, van Driel WJ, Slangen BFM, et al. Impact of the COVID-19-pandemic on patients with gynecological malignancies undergoing surgery: A Dutch population-based study using data from the 'Dutch Gynecological Oncology Audit'. Gynecol Oncol. 2022. PMID: 35221132. doi:10.1016/j.ygyno.2022.02.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。